Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01299480
What this trial is testing

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Who this might be right for
Meningococcal Vaccine
Pfizer 1,714
Early research (Phase 1)Study completedNCT03049488
What this trial is testing

Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus
National Institute of Allergy and Infectious Diseases (NIAID) 95
Early research (Phase 1)Study completedNCT02572388
What this trial is testing

Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1

Who this might be right for
Malaria
University of Oxford 31
Large-scale testing (Phase 3)UnknownNCT05668650
What this trial is testing

Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Laboratorio Elea Phoenix S.A. 174
Post-approval studies (Phase 4)Study completedNCT00163540
What this trial is testing

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Testing effectiveness (Phase 2)WithdrawnNCT04845191
What this trial is testing

COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines

Who this might be right for
Covid19
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT04072497
What this trial is testing

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

Who this might be right for
Herpes Zoster
Shanghai Institute Of Biological Products 522
Post-approval studies (Phase 4)Study completedNCT02196480
What this trial is testing

23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy

Who this might be right for
Juvenile Idiopathic Arthritis
University of Sao Paulo 27
Early research (Phase 1)Study completedNCT02181088
What this trial is testing

A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5

Who this might be right for
MalariaPlasmodium Falciparum
University of Oxford 26
Post-approval studies (Phase 4)UnknownNCT06587503
What this trial is testing

Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses

Who this might be right for
Ebola Virus DiseaseCOVID-19
University of Birmingham 72
Testing effectiveness (Phase 2)Study completedNCT02347423
What this trial is testing

3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants

Who this might be right for
Poliomyelitis
Statens Serum Institut 824
Large-scale testing (Phase 3)Study completedNCT01339923
What this trial is testing

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,409
Testing effectiveness (Phase 2)Study completedNCT00604175
What this trial is testing

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 319
Testing effectiveness (Phase 2)Active Not RecruitingNCT06272812
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

Who this might be right for
Tuberculosis (TB)
International AIDS Vaccine Initiative 5,500
Early research (Phase 1)UnknownNCT06159101
What this trial is testing

Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects

Who this might be right for
Healthy Male Volunteers
Shanghai Henlius Biotech 304
Large-scale testing (Phase 3)Study completedNCT05869201
What this trial is testing

Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

Who this might be right for
InfluenzaInfluenza, HumanInfluenza Viral Infections+2 more
St. Petersburg Research Institute of Vaccines and Sera 450
Testing effectiveness (Phase 2)Study completedNCT00989612
What this trial is testing

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)

Who this might be right for
Influenza
GlaxoSmithKline 100
Post-approval studies (Phase 4)Study completedNCT01430819
What this trial is testing

Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 300
Large-scale testing (Phase 3)WithdrawnNCT02082639
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT06106581
What this trial is testing

Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years

Who this might be right for
Chikungunya Virus Infection
Valneva Austria GmbH 304
Next Page